These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7717569)

  • 1. Glycine receptor antagonism. Effects of ACEA-1021 on the minimum alveolar concentration for halothane in the rat.
    McFarlane C; Warner DS; Nader A; Dexter F
    Anesthesiology; 1995 Apr; 82(4):963-8. PubMed ID: 7717569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA receptor competitive antagonism reduces halothane MAC in rats.
    McFarlane C; Warner DS; Todd MM; Nordholm L
    Anesthesiology; 1992 Dec; 77(6):1165-70. PubMed ID: 1334638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glycine receptor antagonism on spreading depression in the rat.
    Martin H; Warner DS; Todd MM
    Neurosci Lett; 1994 Oct; 180(2):285-9. PubMed ID: 7700595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.
    Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM
    Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
    Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E
    Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine receptors mediate part of the immobility produced by inhaled anesthetics.
    Zhang Y; Laster MJ; Hara K; Harris RA; Eger EI; Stabernack CR; Sonner JM
    Anesth Analg; 2003 Jan; 96(1):97-101, table of contents. PubMed ID: 12505932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of NMDA receptor glycine recognition site antagonism: dependence on glycine concentration.
    Pearlstein RD; Beirne JP; Massey GW; Warner DS
    J Neurochem; 1998 May; 70(5):2012-9. PubMed ID: 9572287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor.
    Lingenhöhl K; Pozza MF
    Neuropharmacology; 1998 Jun; 37(6):729-37. PubMed ID: 9707286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists.
    Warner DS; Martin H; Ludwig P; McAllister A; Keana JF; Weber E
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):188-96. PubMed ID: 7860652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of NMDA receptor glycine recognition site antagonism on cerebral metabolic rate for glucose and cerebral blood flow in the conscious rat.
    Morimoto Y; Wu B; Bart RD; Morimoto Y; Pearlstein RD; Warner DS
    Brain Res; 1998 Jan; 779(1-2):170-6. PubMed ID: 9473659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
    Nishiyama T
    Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
    Lutfy K; Doan P; Nguyen M; Weber E
    Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity.
    Matsumoto RR; Brackett RL; Kanthasamy AG
    Eur J Pharmacol; 1997 Nov; 338(3):233-42. PubMed ID: 9424017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between NMDA and AMPA glutamate receptor antagonists during halothane anesthesia in the rat.
    McFarlane C; Warner DS; Dexter F
    Neuropharmacology; 1995 Jun; 34(6):659-63. PubMed ID: 7566502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
    Lutfy K; Shen KZ; Woodward RM; Weber E
    Brain Res; 1996 Aug; 731(1-2):171-81. PubMed ID: 8883867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist.
    Lutfy K; Shen KZ; Kwon IS; Cai SX; Woodward RM; Keana JF; Weber E
    Eur J Pharmacol; 1995 Jan; 273(1-2):187-9. PubMed ID: 7737313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.
    Keana JF; Kher SM; Cai SX; Dinsmore CM; Glenn AG; Guastella J; Huang JC; Ilyin V; Lü Y; Mouser PL
    J Med Chem; 1995 Oct; 38(22):4367-79. PubMed ID: 7473565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
    Lutfy K; Doan P; Weber E
    Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice.
    Lutfy K; Weber E
    Brain Res; 1996 Dec; 743(1-2):17-23. PubMed ID: 9017225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain.
    Hawkinson JE; Huber KR; Sahota PS; Han Hsu H; Weber E; Whitehouse MJ
    Brain Res; 1997 Jan; 744(2):227-34. PubMed ID: 9027382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.